Myeloid cell dysfunction and the pathogenesis of the diabetic chronic wound

Seminars in Immunology

Volumn 26, Issue 4, 2014, Pages 341-353

  Wicks, Kate ^a   Torbica, Tanja ^a   Mace, Kimberly A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Chromatin regulation; Chronic inflammation; Chronic wound; Diabetes; Macrophage polarisation; Myeloid cell

Indexed keywords

CD11B ANTIGEN; CELL SURFACE MARKER; INTRINSIC FACTOR;

ADIPOSE TISSUE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL EXPANSION; CELL HETEROGENEITY; CELL MATURATION; CELL POPULATION; CHRONIC WOUND; DIABETES MELLITUS; EXTRACELLULAR MATRIX; HISTONE MODIFICATION; HUMAN; INFLAMMATION; INFLAMMATORY CELL; MACROPHAGE; MONOCYTE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; STEM CELL NICHE; WOUND HEALING; ANIMAL; IMMUNOLOGY; MOUSE; PATHOLOGY;

ANIMALS; DIABETES COMPLICATIONS; HUMANS; INFLAMMATION; MICE; MYELOID CELLS; WOUND HEALING;

EID: 84922916712     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2014.04.006     Document Type: Review

References (140)

1. Guo S., DiPietro L.A. Factors affecting wound healing. J Dent Res 2010, 89:219-229.
2. Karsdal M.A., Woodworth T., Henriksen K., Maksymowych W.P., Genant H., Vergnaud P., et al. Biochemical markers of ongoing joint damage in rheumatoid arthritis - current and future applications, limitations and opportunities. Arthritis Res Ther 2011, 2011.
3. Rogler G. Inflammatory bowel disease cancer risk, detection and surveillance. Dig Dis 2012, 30:48-54.
4. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
5. Williams M.D., Nadler J.L. Inflammatory mechanisms of diabetic complications. Curr Diab Rep 2007, 7:242-248.
6. WHO Diabetes fact sheet 2013, World Health Organization.
7. Forbes J.M., Cooper M.E. Mechanisms of diabetic complications. Physiol Rev 2013, 93:137-188.
8. Brem H., Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007, 117:1219-1222.
9. Diabetes U. Diabetes in the UK 2012. Key statistics on diabetes 2012.
10. Egro F.M. Why is type 1 diabetes increasing?. J Mol Endocrinol 2013, 51:R1-R13.
11. Holden S.E., Barnett A.H., Peters J.R., Jenkins-Jones S., Poole C.D., Morgan C.L., et al. The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010. Diab Obes Metab 2013, 15:844-852.
12. IDF Diabetes: facts and figures International Diabetes Federation 2013.
13. Hex N., Bartlett C., Wright D., Taylor M., Varley D. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diab Med 2012, 29:855-862.
14. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54:1615-1625.
15. Acosta J.B., del Barco D.G., Vera D.C., Savigne W., Lopez-Saura P., Nieto G.G., et al. The pro-inflammatory environment in recalcitrant diabetic foot wounds. Int Wound J 2008, 5:530-539.
16. NDIC National Diabetes Statistics, 2011 2011, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
17. Soehnlein O., Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 2010, 10:427-439.
18. Like A.A., Rossini A.A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 1976, 193:415-417.
19. Makino S., Kunimoto K., Muraoka Y., Mizushima Y., Katagiri K., Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 1980, 29:1-13.
20. Ingalls A.M., Dickie M.M., Snell G.D. Obese, a new mutation in the house mouse. J Hered 1950, 41:317-318.
21. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
22. Hummel K.P., Dickie M.M., Coleman D.L. Diabetes, a new mutation in the mouse. Science 1966, 153:1127-1128.
23. Chen H., Charlat O., Tartaglia L.A., Woolf E.A., Weng X., Ellis S.J., et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996, 84:491-495.
24. Maruyama T., Takei I., Taniyama M., Kataoka K., Matsuki S. Immunological aspect of non-obese diabetic mice: immune islet cell-killing mechanism and cell-mediated immunity. Diabetologia 1984, 27:121-123.
25. Seitz O., Schürmann C., Hermes N., Müller E., Pfeilschifter J., Frank S., et al. Wound healing in mice with high-fat diet- or ob gene-induced diabetes-obesity syndromes: a comparative study. Exp Diab Res 2010, 2010:1-15.
26. Geering B., Stoeckle C., Conus S., Simon H.-U. Living and dying for inflammation: neutrophils, eosinophils, basophils. Trends Immunol 2013, 34:398-409.
27. Arnardottir H.H., Freysdottir J., Hardardottir I. Two circulating neutrophil populations in acute inflammation in mice. Inflamm Res 2012, 61:931-939.
28. Gauvreau G.M., Ellis A.K., Denburg J.A. Haemopoietic processes in allergic disease: eosinophil/basophil development. Clin Exp Allergy 2009, 39:1297-1306.
29. Shi C., Pamer E.G. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011, 11:762-774.
30. Meszaros A., Reichner J.S., Albina J.E. Macrophage phagocytosis of wound neutrophils. J Leukoc Biol 1999, 65:35-42.
31. Yona S., Kim K.W., Wolf Y., Mildner A., Varol D., Breker M., et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 2013, 38:79-91.
32. Mace K.A., Restivo T.E., Rinn J.L., Paquet A.C., Chang H.Y., Young D.M., et al. HOXA3 modulates injury-induced mobilization and recruitment of bone marrow-derived cells. Stem Cells 2009, 27:1654-1665.
33. Jenkins S.J., Ruckerl D., Cook P.C., Jones L.H., Finkelman F.D., van Rooijen N., et al. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 2011, 332:1284-1288.
34. Mirza R., DiPietro L.A., Koh T.J. Selective and specific macrophage ablation is detrimental to wound healing in mice. Am J Pathol 2009, 175:2454-2462.
35. Lucas T., Waisman A., Ranjan R., Roes J., Krieg T., Muller W., et al. Differential roles of macrophages in diverse phases of skin repair. J Immunol 2010, 184:3964-3977.
36. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
37. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
38. Hazra S., Jarajapu Y.P., Stepps V., Caballero S., Thinschmidt J.S., Sautina L., et al. Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine model. Diabetologia 2013, 56:644-653.
39. Willenborg S., Lucas T., van Loo G., Knipper J.A., Krieg T., Haase I., et al. CCR2 recruits an inflammatory macrophage subpopulation critical for angiogenesis in tissue repair. Blood 2012, 120:613-625.
40. Ingersoll M.A., Platt A.M., Potteaux S., Randolph G.J. Monocyte trafficking in acute and chronic inflammation. Trends Immunol 2011, 32:470-477.
41. Davies L.C., Rosas M., Jenkins S.J., Liao C.-T., Scurr M.J., Brombacher F., et al. Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation. Nat Commun 2013, 4:1886.
42. Bannon P., Wood S., Restivo T., Campbell L., Hardman M.J., Mace K.A. Diabetes induces stable intrinsic changes to myeloid cells that contribute to chronic inflammation during wound healing in mice. Dis Models Mech 2013, 6:1434-1447.
43. Sunderkötter C., Nikolic T., Dillon M.J., van Rooijen N., Stehling M., Drevets D.A., et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 2004, 172:4410-4417.
44. Auffray C., Fogg D., Garfa M., Elain G., Join-Lambert O., Kayal S., et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007, 317:666-670.
45. Sasmono R.T., Ehrnsperger A., Cronau S.L., Ravasi T., Kandane R., Hickey M.J., et al. Mouse neutrophilic granulocytes express mRNA encoding the macrophage colony-stimulating factor receptor (CSF-1R) as well as many other macrophage-specific transcripts and can transdifferentiate into macrophages in vitro in response to CSF-1. J Leukoc Biol 2007, 82:111-123.
46. Hirsch S., Austyn J.M., Gordon S. Expression of the macrophage-specific antigen F4/80 during differentiation of mouse bone marrow cells in culture. J Exp Med 1981, 154:713-725.
47. Gordon S., Hamann J., Lin H.-H., Stacey M. F4/80 and the related adhesion-GPCRs. Eur J Immunol 2011, 41:2470-2525.
48. Saini A., Liu Y.J., Cohen D.J., Ooi B.S. Hyperglycemia augments macrophage growth response to colony stimulating factor-1. Metabolism 1996, 45:1125-1129.
49. Liu W., Xu G.Z., Jiang C.H., Da C.D. Expression of macrophage colony-stimulating factor (M-CSF) and its receptor in streptozotocin-induced diabetic rats. Curr Eye Res 2009, 34:123-133.
50. Yu D.H., Mace K.A., Hansen S.L., Boudreau N., Young D.M. Effects of decreased insulin-like growth factor-1 stimulation on hypoxia inducible factor 1-alpha protein synthesis and function during cutaneous repair in diabetic mice. Wound Rep Regen: Off Publ Wound Heal Soc Eur Tissue Rep Soc 2007, 15:628-635.
51. Hamilton R.T., Bhattacharya A., Walsh M.E., Shi Y., Wei R., Zhang Y., et al. Elevated protein carbonylation, and misfolding in sciatic nerve from db/db and Sod1(-/-) mice: plausible link between oxidative stress and demyelination. PLoS ONE 2013, 8:e65725.
52. Mirza R., Koh T.J. Dysregulation of monocyte/macrophage phenotype in wounds of diabetic mice. Cytokine 2011, 56:256-264.
53. Serbina N.V., Pamer E.G. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 2006, 7:311-317.
54. Cipolletta C., Ryan K.E., Hanna E.V., Trimble E.R. Activation of peripheral blood CD14+ monocytes occurs in diabetes. Diabetes 2005, 54:2779-2786.
55. Jacquelin S., Licata F., Dorgham K., Hermand P., Poupel L., Guyon E., et al. CX3CR1 reduces Ly6Chigh-monocyte motility within and release from the bone marrow after chemotherapy in mice. Blood 2013, 122:674-683.
56. Yona S., Jung S. Monocytes: subsets, origins, fates and functions. Curr Opin Hematol 2010, 17:53-59.
57. Ziegler-Heitbrock L., Ancuta P., Crowe S., Dalod M., Grau V., Hart D.N., et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010, 116:e74-e80.
58. Koch S., Kucharzik T., Heidemann J., Nusrat A., Luegering A. Investigating the role of proinflammatory CD16+ monocytes in the pathogenesis of inflammatory bowel disease. Clin Exp Immunol 2010, 161:332-341.
59. Min D., Brooks B., Wong J., Salomon R., Bao W., Harrisberg B., et al. Alterations in monocyte CD16 in association with diabetes complications. Mediat Inflamm 2012, 2012:649083.
60. Wong K.L., Tai J.J., Wong W.C., Han H., Sem X., Yeap W.H., et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 2011, 118:e16-e31.
61. Ingersoll M.A., Spanbroek R., Lottaz C., Gautier E.L., Frankenberger M., Hoffmann R., et al. Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 2010, 115(3):e10-e19. [Blood. 2010;116:857-857].
62. Fleming T., Fleming M., Malek T. Selective expression of Ly6-G on myeloid lineage cells in mouse bone marrow. J Immunol 1993, 151:2399-2408.
63. Mahdipour E., Charnock J.C., Mace K.A. Hoxa3 promotes the differentiation of hematopoietic progenitor cells into proangiogenic Gr-1+CD11b+ myeloid cells. Blood 2011, 117:815-826.
64. Zhang C., Lei G.S., Shao S., Jung H.W., Durant P.J., Lee C.H. Accumulation of myeloid-derived suppressor cells in the lungs during Pneumocystis pneumonia. Infect Immun 2012, 80:3634-3641.
65. Yang L., DeBusk L.M., Fukuda K., Fingleton B., Green-Jarvis B., Shyr Y., et al. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 2004, 6:409-421.
66. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009, 9:162-174.
67. Youn J.-I., Kumar V., Collazo M., Nefedova Y., Condamine T., Cheng P., et al. Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. Nat Immunol 2013, 14:211-220.
68. Morin J., Chimènes A., Boitard C., Berthier R., Boudaly S. Granulocyte-dendritic cell unbalance in the non-obese diabetic mice. Cell Immunol 2003, 223:13-25.
69. Nagaraj S., Gabrilovich D.I. Myeloid-derived suppressor cells in human cancer. Cancer J 2010, 16:348-353.
70. Khaled Y.S., Ammori B.J., Elkord E. Myeloid-derived suppressor cells in cancer: recent progress and prospects. Immunol Cell Biol 2013, 91:493-502.
71. Gurtner G.C., Werner S., Barrandon Y., Longaker M.T. Wound repair and regeneration. Nature 2008, 453:314-321.
72. Barrientos S., Stojadinovic O., Golinko M.S., Brem H., Tomic-Canic M. Perspective article: growth factors and cytokines in wound healing. Wound Repair Regen 2008, 16:585-601.
73. Wetzler C., Kaempfer H., Stallmeyer B., Pfeilschifter J., Frank S. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 2000, 115:245-253.
74. Lech M., Gröbmayr R., Weidenbusch M., Anders H.-J. Tissues use resident dendritic cells and macrophages to maintain homeostasis and to regain homeostasis upon tissue injury: the immunoregulatory role of changing tissue environments. Mediat Inflamm 2012, 2012:1-15.
75. Leibovich S.J., Ross R. The role of the macrophage in wound healing. Am J Pathol 1975, 78:71-100.
76. Goren I., Allmann N., Yogev N., Schürmann C., Linke A., Holdener M., et al. A transgenic mouse model of inducible macrophage depletion. Am J Pathol 2009, 175:132-147.
77. Loots M.A., Lamme E.N., Zeegelaar J., Mekkes J.R., Bos J.D., Middelkoop E. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 1998, 111:850-857.
78. Goova M.T., Li J., Kislinger T., Qu W., Lu Y., Bucciarelli L.G., et al. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 2001, 159:513-525.
79. Dovi J.V., He L.K., DiPietro L.A. Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol 2003, 73:448-455.
80. Goren I., Muller E., Schiefelbein D., Christen U., Pfeilschifter J., Muhl H., et al. Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. J Invest Dermatol 2007, 127:2259-2267.
81. Daley J.M., Brancato S.K., Thomay A.A., Reichner J.S., Albina J.E. The phenotype of murine wound macrophages. J Leukoc Biol 2010, 87:59-67.
82. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012, 122:787-795.
83. Bystrom J., Evans I., Newson J., Stables M., Toor I., van Rooijen N., et al. Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood 2008, 112:4117-4127.
84. Sindrilaru A., Peters T., Wieschalka S., Baican C., Baican A., Peter H., et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest 2011, 121:985-997.
85. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35.
86. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686.
87. Jetten N., Verbruggen S., Gijbels M.J., Post M.J., Winther M.P.J., Donners M.M.P.C. Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis 2013, 17:109-118.
88. Fridlender Z.G., Sun J., Kim S., Kapoor V., Cheng G., Ling L., et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: N1 versus N2 TAN. Cancer Cell 2009, 16:183-194.
89. Mantovani A., Biswas S.K., Galdiero M.R., Sica A., Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013, 229:176-185.
90. Müller A.-K., Meyer M., Werner S. The roles of receptor tyrosine kinases and their ligands in the wound repair process. Semin Cell Dev Biol 2012, 23:963-970.
91. Bainbridge P. Wound healing and the role of fibroblasts. J Wound Care 2013, 22:407-412.
92. Arroyo A.G., Iruela-Arispe M.L. Extracellular matrix, inflammation, and the angiogenic response. Cardiovasc Res 2010, 86:226-235.
93. Miao M., Niu Y., Xie T., Yuan B., Qing C., Lu S. Diabetes-impaired wound healing and altered macrophage activation: a possible pathophysiologic correlation. Wound Repair Regen 2012, 20:203-213.
94. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998, 101:890-898.
95. Arnold L., Henry A., Poron F., Baba-Amer Y., van Rooijen N., Plonquet A., et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 2007, 204:1057-1069.
96. O'Brien B.A., Huang Y., Geng X., Dutz J.P., Finegood D.T. Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes 2002, 51:2481-2488.
97. O'Brien B.A., Geng X., Orteu C.H., Huang Y., Ghoreishi M., Zhang Y., et al. A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse. J Autoimmun 2006, 26:104-115.
98. Marée A.F.M., Komba M., Finegood D.T., Edelstein-Keshet L. A quantitative comparison of rates of phagocytosis and digestion of apoptotic cells by macrophages from normal (BALB/c) and diabetes-prone (NOD) mice. J Appl Physiol 2008, 104:157-169.
99. Bradshaw E.M., Raddassi K., Elyaman W., Orban T., Gottlieb P.A., Kent S.C., et al. Monocytes from patients with Type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. J Immunol 2009, 183:4432-4439.
100. Han J.M., Levings M.K. Immune regulation in obesity-associated adipose inflammation. J Immunol 2013, 191:527-532.
101. Carvalheira J.B.C.C. Blood spotlight on leukocytes and obesity. Blood 2013, 122:3263-3267.
102. Chmelar J., Chung K.J., Chavakis T. The role of innate immune cells in obese adipose tissue inflammation and development of insulin resistance. Thromb Haemost 2013, 109:399-406.
103. Gilbert C.A., Slingerland J.M. Cytokines, obesity, and cancer new insights on mechanisms linking obesity to cancer risk and progression. Annu Rev Med 2013, 64:45-57.
104. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005, 115:911-919.
105. Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007, 117:175-184.
106. Oh D.Y., Morinaga H., Talukdar S., Bae E.J., Olefsky J.M. Increased macrophage migration into adipose tissue in obese mice. Diabetes 2012, 61:346-354.
107. Morris D.L., Cho K.W., Delproposto J.L., Oatmen K.E., Geletka L.M., Martinez-Santibanez G., et al. Adipose tissue macrophages function as antigen-presenting cells and regulate adipose tissue CD4+ T cells in mice. Diabetes 2013, 62:2762-2772.
108. Xia S., Sha H., Yang L., Ji Y., Ostrand-Rosenberg S., Qi L. Gr-1+ CD11b+ myeloid-derived suppressor cells suppress inflammation and promote insulin sensitivity in obesity. J Biol Chem 2011, 286:23591-23599.
109. Schultz G.S., Davidson J.M., Kirsner R.S., Bornstein P., Herman I.M. Dynamic reciprocity in the wound microenvironment. Wound Repair Regen 2011, 19:134-148.
110. Martins V.L., Caley M., O'Toole E.A. Matrix metalloproteinases and epidermal wound repair. Cell Tissue Res 2012, 351:255-268.
111. Dalton S.J., Mitchell D.C., Whiting C.V., Tarlton J.F. Abnormal extracellular matrix metabolism in chronically ischemic skin: a mechanism for dermal failure in leg ulcers. J Invest Dermatol 2005, 125:373-379.
112. Rayment E.A., Upton Z., Shooter G.K. Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer. Br J Dermatol 2008, 158:951-961.
113. Gooyit M., Peng Z., Wolter W.R., Pi H., Ding D., Hesek D., et al. A chemical biological strategy to facilitate diabetic wound healing. ACS Chem Biol 2014, 9:105-110.
114. Richard J.L., Martini J., Bonello Faraill M.M., M'Bempa J.M., Lepeut M., Truchetet F., et al. Management of diabetic fot ulcers with a TLC-NOSF wound dressing. J Wound Care 2012, 21:142-147.
115. Mirza R.E., Fang M.M., Weinheimer-Haus E.M., Ennis W.J., Koh T.J. Sustained inflammasome activity in macrophages impairs wound healing in Type 2 diabetic humans and mice. Diabetes 2013, 63:1103-1114.
116. Kanter J.E., Kramer F., Barnhart S., Averill M.M., Vivekanandan-Giri A., Vickery T., et al. Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. Proc Natl Acad Sci 2012, 109:E715-E724.
117. Oikawa A., Siragusa M., Quaini F., Mangialardi G., Katare R.G., Caporali A., et al. Diabetes mellitus induces bone marrow microangiopathy. Arterioscl Thromb Vasc Biol 2010, 30:498-508.
118. Orlandi A., Chavakis E., Seeger F., Tjwa M., Zeiher A.M., Dimmeler S. Long-term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice. Basic Res Cardiol 2010, 105:703-712.
119. Bories G., Caiazzo R., Derudas B., Copin C., Raverdy V., Pigeyre M., et al. Impaired alternative macrophage differentiation of peripheral blood mononuclear cells from obese subjects. Diab Vasc Dis Res: Off J Int Soc Diab Vasc Dis 2012, 9:189-195.
120. Griseri T., McKenzie B.S., Schiering C., Powrie F. Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation. Immunity 2012, 37:1116-1129.
121. Esplin B.L., Shimazu T., Welner R.S., Garrett K.P., Nie L., Zhang Q., et al. Chronic exposure to a TLR ligand injures hematopoietic stem cells. J Immunol 2011, 186:5367-5375.
122. Liu Z.H., Chen L.L., Deng X.L., Song H.J., Liao Y.F., Zeng T.S., et al. Methylation status of CpG sites in the MCP-1 promoter is correlated to serum MCP-1 in Type 2 diabetes. J Endocrinol Invest 2012, 35:585-589.
123. Miao F., Gaw Gonzalo I., Lanting L., Natarajan R. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 2004, 279:18091-18097.
124. Miao F., Wu X., Zhang L., Yuan Y.C., Riggs A.D., Natarajan R. Genome-wide analysis of histone lysine methylation variations caused by diabetic conditions in human monocytes. J Biol Chem 2007, 282:13854-13863.
125. Miao F., Chen Z., Zhang L., Wang J., Gao H., Wu X., et al. RNA-sequencing analysis of high glucose-treated monocytes reveals novel transcriptome signatures and associated epigenetic profiles. Physiol Genomics 2013, 45:287-299.
126. Dang M.N., Buzzetti R., Pozzilli P. Epigenetics in autoimmune diseases with focus on type 1 diabetes. Diab/Metab Res Rev 2013, 29:8-18.
127. LeRoy G., DiMaggio P.A., Chan E.Y., Zee B.M., Blanco M.A., Bryant B., et al. A quantitative atlas of histone modification signatures from human cancer cells. Epigenet Chromatin 2013, 6:20.
128. Garrigan E., Belkin N.S., Alexander J.J., Han Z., Seydel F., Carter J., et al. Persistent STAT5 phosphorylation and epigenetic dysregulation of GM-CSF and PGS2/COX2 expression in Type 1 diabetic human monocytes. PLoS ONE 2013, 8:e76919.
129. Lu Y.-C., Yeh W.-C., Ohashi P.S. LPS/TLR4 signal transduction pathway. Cytokine 2008, 42:145-151.
130. Rodriguez S., Chora A., Goumnerov B., Mumaw C., Goebel W.S., Fernandez L., et al. Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsis. Blood 2009, 114:4064-4076.
131. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
132. Salgin B., Ong K.K., Thankamony A., Emmett P., Wareham N.J., Dunger D.B. Higher fasting plasma free fatty acid levels are associated with lower insulin secretion in children and adults and a higher incidence of Type 2 diabetes. J Clin Endocrinol Metab 2012, 97:3302-3309.
133. Mahendran Y., Cederberg H., Vangipurapu J., Kangas A., Soininen P., Kuusisto J., et al. Glycerol and fatty acids in serum predict the development of hyperglycemia and Type 2 diabetes in Finnish men. Diabetes Care 2013, 36:3732-3738.
134. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006, 116:3015-3025.
135. Lassenius M.I., Pietilainen K.H., Kaartinen K., Pussinen P.J., Syjanen J., Forsiblom C., et al. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity and chronic inflammation. Diabetes Care 2011, 34:1809-1815.
136. Devaraj S., Dasu M.R., Rockwood J., Winter W., Griffen S.C., Jialal I. Increased Toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with Type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 2008, 93:578-583.
137. Dasu M.R., Devaraj S., Zhao L., Hwang D.H., Jialal I. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 2008, 57:3090-3098.
138. Dasu M.R., Jialal I. Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors. Am J Physiol Endocrinol Metab 2011, 300:E145-E154.
139. Aung H.T. LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression. FASEB J 2006, 20:1315-1327.
140. Foster S.L., Hargreaves D.C., Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007, 447:972-978.